Co-Diagnostics's total assets for Q4 2025 were $24.74M, a decrease of -44.70% from the previous quarter. DE:C970 total liabilities were $4.11M for the fiscal quarter, a -16.26% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.